Solana Co key statistics and ratios
In fiscal 2025, Solana Co had return on equity of -27.1%, an operating margin of -4052.5%, debt equal to 0.0% of equity and a current ratio of 10.33. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 100.0% | 43.4% | 41.3% | 42.9% | 41.2% | 9.5% | −11.9% | 91.7% | 95.5% |
| Operating margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Net margin | <−999% | −653.8% | <−999% | <−999% | <−999% | <−999% | <−999% | −679.6% | <−999% |
| Free-cash-flow margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | −274.5% | −223.2% |
| Return on equity | — | −124.7% | — | — | −145.0% | −168.6% | — | −27.1% | −67.4% |
| Return on assets | −102.9% | −51.2% | −167.3% | −175.6% | −89.7% | −70.9% | −209.0% | −26.6% | −65.5% |
| Asset turnover | 0.02 | 0.08 | 0.08 | 0.05 | 0.05 | 0.05 | 0.09 | 0.04 | 0.05 |
| Current ratio | 1.50 | 1.90 | 1.93 | 4.75 | 8.40 | 3.96 | 1.58 | 10.33 | 13.31 |
| Debt to equity | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Effective tax rate | — | 0.0% | — | — | — | — | — | — | — |
| R&D as % of revenue | >999% | 538.8% | 693.2% | >999% | 541.6% | 456.8% | 703.7% | 58.4% | — |
| SG&A as % of revenue | >999% | >999% | >999% | >999% | >999% | >999% | >999% | 384.4% | — |
| Capital spending as % of revenue | 92.1% | 18.6% | 9.5% | 10.3% | 2.2% | 4.5% | 1.0% | 0.0% | 0.0% |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | — | −1.3% | — | — | 85.2% | 96.6% | 95.0% | 97.0% |
| Operating margin | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% | <−999% |
| Net margin | <−999% | <−999% | <−999% | <−999% | <−999% | >999% | <−999% | <−999% |
| Free-cash-flow margin | <−999% | <−999% | — | <−999% | −580.2% | −118.2% | −133.4% | −470.8% |
| Current ratio | 3.61 | 1.58 | 1.69 | 4.32 | 40.03 | 10.33 | 9.90 | 13.31 |
| R&D as % of revenue | >999% | 607.9% | >999% | >999% | 123.1% | 16.9% | — | — |
| SG&A as % of revenue | >999% | >999% | >999% | >999% | 666.6% | 249.4% | — | — |
Moat
Weak moat
How hard Solana's competitive advantage looks for rivals to wear away, judged from 7 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.
- Returns on capital 0 / 20
Cash operating profit has been a median -138.1% of total assets over 6 years.
- Pricing power 4 / 20
Gross margin has been a median 34.1%, moving by 51.4 percentage points (standard deviation) across 7 years.
- Durability 10 / 20
Operating margin has been a median -2972.7%; its worst year was -4932.2%.
- Cash conversion 0 / 20
Free cash flow was positive in 0 of 7 years, at a median -2232.4% of revenue.
- Discipline 0 / 20
The diluted share count rose 46809310.9% over five years; stock-based pay has been a median 295.6% of revenue.
AI disruption exposure: Low. In this industry, the business rests on physical assets, regulated networks or products AI itself depends on.
Compare with peers
- Nano-x Imaging Ltd. statistics
- Inspiremd, Inc. statistics
- Work Medical Technology Group LTD statistics
- Neuroone Medical Technologies Corp statistics
- Spectral AI, Inc. statistics
Head to head: HSDT vs NNOXHSDT vs NSPRHSDT vs WOK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies